LANTERN PHARMA INC
LTRN·51654W101·US·Common Stock·Healthcare - Biotechnology-Activist
LTRN (LANTERN PHARMA INC) is held by 28 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.8M), RENAISSANCE TECHNOLOGIES LLC ($1.2M), GEODE CAPITAL MANAGEMENT, LLC ($428,852). Net institutional sentiment: Mixed.
28
Holders
(2 Elite)
$5.2M
Total Value
61% (23)
Consensus
14 buying - 9 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders May 14, 2026 · Activists Aug 4, 2026 · Congress none
ActivistEAEmpery Asset Management, LP10.0%Aug 4, 2026
ActivistTAThomas A. Satterfield, Jr.7.6%Jul 23, 2026
ActivistBABIOS ADVISORS GP, LLC4.5%May 15, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 32
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer